摘要
对446例高脂血症又属中医脾虚、痰瘀阻滞症的患者,进行随机分组。一为血脂康胶囊(由红曲制成,下称血脂康)治疗组3H例,一为阳性药组(下称对照组)122例。8周为1疗程。观察结果,血脂康总显效率为79.7%(258/3H),对照组为31.2%(38/122)。血脂康组总胆固醇(TC)、甘油三酯(TG)下降率分别是23.0%、36.5%,下降明显(P<0.001);高密度脂蛋白胆固醇(HDL一C)上升19.6%,升高明显(P<0.001)。对照组这些指标比疗前也明显下降(P<0.001)。二组相比,总显效率及各项指标的改善,血脂康均优于对照组(P<0.001)。综合分析,血脂康是安全有效的。
In this randonuzed trial,446 patients with hyperlipidemia,who wasalso diagnosed as hypofunction and disorder of Spleen and abundant expectora-tion by traditional Chinese medicine,were divided into two groups:Xuezhikangcapsule一treated group having 324 patients and Jiaogulan tablet一treated groupas a control with 122 patients. At the end of 8 weeks’treatment,the total effectiverate of the capsule was 79.7%, where as the tablet was 31.2%。Xuezhikangsignificantly reduced TC by 23.0%and TG by 36.5%,and raised HDL一C by19.6%(P<0.001).Jiaogulan aslo improved TC,TG and HDL-C markedly.COm-paring the two groups in the total effective rate and the improvement of TC TGand HDL一C,the effect of Xuezhikang capsule was found to be superior to fhat ofJiaogulan(P<0.001).Results indicated that Xuezhikang is an effective and safety preparation.
出处
《中国实验方剂学杂志》
CAS
1995年第1期37-41,共5页
Chinese Journal of Experimental Traditional Medical Formulae